Internal Medicine, Infectious Disease · Marquette, MI
NPI
1457346967
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1414 W Fair Ave, Suite 111
Marquette, MI, 49855
Phone (906) 225-7601
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
441 services
Medicare patients, 2024
157
Average age 71
Drug cost, 2024
$1.5M
1,695 prescriptions
Company payments, 2024
$28.7
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John R Wallace was code 99233 (hospital e&m - subsequent), 145 times for 63 patients. In total John R Wallace billed 441 services in 13 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 145 | 63 | $97.25 | $14K |
| 99214 Office E&M - Established | Office | 88 | 63 | $73.37 | $6,457 |
| 99232 Hospital E&M - Subsequent | Facility | 78 | 37 | $65.05 | $5,074 |
| 99223 Hospital E&M - Initial | Facility | 43 | 43 | $139.32 | $5,991 |
| 99213 Office E&M - Established | Office | 39 | 33 | $47.66 | $1,859 |
By year: 2022 $51K for 695 services; 2023 $40K for 505 services; 2024 $36K for 441 services.
Medicare prescription drug claims, 2024
In 2024, the drug John R Wallace prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 120 prescriptions and refills. In total John R Wallace wrote 1,695 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 120 | 120 | 16 | $472K |
| Cephalexin Generic | 104 | 218 | 34 | $7,453 |
| Doxycycline Hyclate Generic | 85 | 172 | 35 | $2,881 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 77 | 77 | Under 11 | $291K |
| Omeprazole Generic | 59 | 61 | Under 11 | $903 |
| Descovy Emtricitabine/Tenofov Alafenam | 48 | 48 | Under 11 | $107K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 44 | 70 | 14 | $318 |
| Penicillin V Potassium Generic | 43 | 77 | 17 | $1,406 |
| Gabapentin Generic | 38 | 42 | Under 11 | $361 |
| Rifampin Generic | 37 | 46 | 11 | $3,110 |
| Amitriptyline Hcl Generic | 36 | 36 | Under 11 | $291 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 34 | 40 | Under 11 | $155K |
| Ritonavir Generic | 34 | 34 | Under 11 | $3,466 |
| Acyclovir Generic | 33 | 33 | Under 11 | $675 |
| Ampicillin Trihydrate Generic | 33 | 63 | 11 | $1,758 |
Brand drugs: - claims; generic drugs: 1,275 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid John R Wallace $28.7 ($28.7 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $28.7.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $28.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.